C B PHARMA ACQUISITION CORP's ticker is CNLMU and the CUSIP is G2029P100. A total of 7 filers reported holding C B PHARMA ACQUISITION CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $176,000 | -0.6% | 17,300 | 0.0% | 0.00% | – |
| Q4 2015 | $177,000 | -2.7% | 17,300 | -1.1% | 0.00% | – |
| Q3 2015 | $182,000 | -0.5% | 17,500 | 0.0% | 0.00% | – |
| Q2 2015 | $183,000 | -7.6% | 17,500 | -9.8% | 0.00% | – |
| Q1 2015 | $198,000 | -1.5% | 19,400 | -3.0% | 0.00% | – |
| Q4 2014 | $201,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Weiss Asset Management LP | 268,246 | $2,691,000 | 1.09% |
| SENECA CAPITAL INVESTMENTS, L.P. | 150,000 | $1,506,000 | 0.42% |
| Polar Asset Management Partners Inc. | 750,000 | $7,530,000 | 0.40% |
| Context Capital Management, LLC | 14,900 | $150,000 | 0.19% |
| Kassirer Asset Management Corp | 20,000 | $201,000 | 0.18% |
| Bulldog Investors, LLP | 75,000 | $753,000 | 0.16% |
| GLAZER CAPITAL, LLC | 63,424 | $637,000 | 0.09% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 350,000 | $3,511,000 | 0.07% |
| AQR Capital Management | 350,000 | $3,511,000 | 0.01% |
| UBS Group AG | 421 | $4,000 | 0.00% |